AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionNikulski Financial, Inc.
Latest Disclosed Ownership37,482 shares
Latest Disclosed Value $ 8,151,959
Nikulski Financial, Inc. reports 2.70% decrease in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - Nikulski Financial, Inc. filed a 13F-HR form disclosing ownership of 37,482 shares of AbbVie Inc. (DE:4AB) valued at $6,949,163 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 38,524 shares of AbbVie Inc.. This represents a change in shares of -2.70% during the quarter. The current value of the position is $6,960,407 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 37,482 -1,042 -2.70 8,152 -7.40 2.0123
2026-01-15 2025-12-31 13F ABBVIE COM 00287Y109 38,524 -815 -2.07 8,802 -3.36 2.1045
2025-11-05 2025-09-30 13F ABBVIE COM 00287Y109 39,339 -332 -0.84 9,109 23.70 2.2887
2025-08-15 2025-06-30 13F ABBVIE COM 00287Y109 39,671 775 1.99 7,364 -9.65 2.0161
2025-05-01 2025-03-31 13F ABBVIE COM 00287Y109 38,896 -81 -0.21 8,149 17.66 2.4634
2025-01-21 2024-12-31 13F ABBVIE COM 00287Y109 38,977 1,171 3.10 6,926 -7.22 2.0362
2024-10-28 2024-09-30 13F ABBVIE COM 00287Y109 37,806 264 0.70 7,466 15.93 2.2347
2024-07-30 2024-06-30 13F ABBVIE COM 00287Y109 37,542 -769 -2.01 6,439 -7.70 2.0488
2024-04-18 2024-03-31 13F ABBVIE COM 00287Y109 38,311 -383 -0.99 6,976 16.34 2.3137
2024-02-01 2023-12-31 13F ABBVIE COM 00287Y109 38,694 -576 -1.47 5,996 2.44 2.1955
2023-10-17 2023-09-30 13F ABBVIE COM 00287Y109 39,270 5,651 16.81 5,854 29.23 2.4222
2023-07-28 2023-06-30 13F ABBVIE COM 00287Y109 33,619 1,079 3.32 4,529 -12.65 1.8728
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 32,540 -318 -0.97 5,186 -2.35 2.2914
2023-01-25 2022-12-31 13F ABBVIE COM 00287Y109 32,858 120 0.37 5,310 20.85 2.5318
2022-10-20 2022-09-30 13F ABBVIE COM 00287Y109 32,738 100 0.31 4,394 -12.10 2.2738
2022-07-19 2022-06-30 13F ABBVIE COM 00287Y109 32,638 -75 -0.23 4,999 -5.73 2.4803
2022-04-08 2022-03-31 13F ABBVIE COM 00287Y109 32,713 691 2.16 5,303 22.30 2.2428
2022-02-01 2021-12-31 13F ABBVIE COM 00287Y109 32,022 1,075 3.47 4,336 29.90 1.8174
2021-11-05 2021-09-30 13F ABBVIE COM 00287Y109 30,947 663 2.19 3,338 -5.79 1.5435
2021-08-11 2021-06-30 13F ABBVIE COM 00287Y109 30,284 -554 -1.80 3,543 6.17 1.6502
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 30,838 -378 -1.21 3,337 -0.24 1.7110
2021-02-09 2020-12-31 13F/A-1 ABBVIE COM 00287Y109 31,216 1,661 5.62 3,345 29.20 1.8347
2021-02-04 2020-12-31 13F ABBVIE COM 00287Y109 29,555 0 2,589 1,641,735.2044
2020-11-10 2020-09-30 13F ABBVIE COM 00287Y109 29,555 487 1.68 2,589 -9.29 1.6417
2020-07-17 2020-06-30 13F ABBVIE COM 00287Y109 29,068 582 2.04 2,854 31.52 2.0028
2020-04-29 2020-03-31 13F ABBVIE COM 00287Y109 28,486 -1,804 -5.96 2,170 -13.89 1.8931
2020-02-04 2019-12-31 13F ABBVIE COM 00287Y109 30,290 -737 -2.38 2,520 10.28 1.8231
2019-10-22 2019-09-30 13F ABBVIE COM 00287Y109 31,027 1,118 3.74 2,285 11.85 1.9039
2019-07-22 2019-06-30 13F ABBVIE COM 00287Y109 29,909 -3,644 -10.86 2,043 -24.45 1.7266
2019-04-12 2019-03-31 13F ABBVIE COM 00287Y109 33,553 -2,040 -5.73 2,704 -17.59 2.6334
2019-01-25 2018-12-31 13F ABBVIE COM 00287Y109 35,593 -796 -2.19 3,281 15.81 3.4438
2018-11-02 2018-09-30 13F ABBVIE COM 00287Y109 36,389 5,306 17.07 2,833 -1.63 2.6406
2018-08-10 2018-06-30 13F ABBVIE COM 00287Y109 31,083 506 1.65 2,880 -0.48 2.6544
2018-05-11 2018-03-31 13F ABBVIE COM 00287Y109 30,577 1,854 6.45 2,894 4.18 2.8705
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 28,723 28,723 2,778 2.9964
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.